Cargando…
The Centrality of Obesity in the Course of Severe COVID-19
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global public health challenge. Most patients do not experience severe complications, but approximately 25% of patients progress to acute respiratory...
Autores principales: | Liu, Danfei, Zhang, Tongyue, Wang, Yijun, Xia, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992974/ https://www.ncbi.nlm.nih.gov/pubmed/33776917 http://dx.doi.org/10.3389/fendo.2021.620566 |
Ejemplares similares
-
Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020) -
FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021) -
The roles of nausea and vomiting in COVID-19: did we miss something?
por: Zhang, Tongyue, et al.
Publicado: (2021) -
The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight
por: Zhang, Tongyue, et al.
Publicado: (2021) -
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Liu, Danfei, et al.
Publicado: (2021)